Holding(s) in Company
September 22 2003 - 11:34AM
UK Regulatory
RNS Number:0269Q
British Biotech PLC
22 September 2003
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
British Biotech plc
2. Name of shareholder having a major interest
FMR Corp and its direct and indirect subsidiaries; and Fidelity Investment Ltd
and its direct and indirect subsidiaries
3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18
Notification indicates that it is in respect of a non-beneficial interest.
4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them
Mellon Bank 185,647
Chase Manhatten Bank London 6,249,853
HSBC 267,072
Chase Manhatten Bank London 609,276
State Street Bank & Trust 53,382
5. Number of shares / amount of stock acquired
n/a
6. Percentage of issued class
n/a
7. Number of shares / amount of stock disposed
n/a
8. Percentage of issued class
n/a
9. Class of security
Ordinary 5p shares
10. Date of transaction
n/a
11. Date company informed
22 September, 2003
12. Total holding following this notification
7,365,230
13. Total percentage holding of issued class following this notification
5.47 per cent (based on issued shared capital of 134,694,961 shares at 22
September 2003)
14. Any additional information
Notification is in respect of acquisition of British Biotech shares following
the merger of British Biotech pc and Vernalis Group plc.
15. Name of contact and telephone number for queries
Tony Weir + 44 1 865 781166
16. Name and signature of authorised company official responsible for making
this notification
Tony Weir, Finance Director
Date of notification
22 September, 2003
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLTMATMMJTBJJ